Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Octagon Capital Advisors is a New York-based hedge fund and investment adviser focused on public and private healthcare companies globally. The firm manages over $500 million in assets as of early 2025, with significant holdings in biotechnology and pharmaceutical equities. It was established in 2019 and has become known for its active portfolio management within the healthcare sector[1][2][3][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Octagon Capital Advisors.